Literature DB >> 21816780

Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug.

Insug Kang1, Sang-Wook Kim, Jang H Youn.   

Abstract

CONTEXT: Nicotinic acid (NA), or niacin, lowers circulating levels of lipids, including triglycerides, very low-density lipoprotein-cholesterol, and low-density lipoprotein-cholesterol. The lipid-lowering effects have been attributed to its effect to inhibit lipolysis in adipocytes and thus lower plasma free fatty acid (FFA) level. However, evidence accumulates that the FFA-lowering effect may account for only a fraction of NA effects on plasma lipids, and other mechanisms may be involved. Recent studies have reported NA effects on gene expression in various tissues in vivo and in cultured cells in vitro. EVIDENCE ACQUISITION: We reviewed articles reporting NA effects on gene expression, identified by searching PubMed, focusing on potential underlying mechanisms and implications for unexplained NA effects.
CONCLUSION: The effects of NA on gene expression may be mediated directly via the NA receptor in the affected cells, indirectly via changes in circulating FFA or hormone levels induced by NA, or by activating the transcription factor FOXO1 in insulin-sensitive tissues. NA effects on gene expression provide new insights into previously unexplained NA effects, such as FFA-independent lipid-lowering effects, FFA rebound, and insulin resistance observed in clinics during NA treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816780      PMCID: PMC3200242          DOI: 10.1210/jc.2011-1104

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  78 in total

1.  Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.

Authors:  José W A van der Hoorn; Willeke de Haan; Jimmy F P Berbée; Louis M Havekes; J Wouter Jukema; Patrick C N Rensen; Hans M G Princen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

2.  3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.

Authors:  Graeme Semple; Philip J Skinner; Tawfik Gharbaoui; Young-Jun Shin; Jae-Kyu Jung; Martin C Cherrier; Peter J Webb; Susan Y Tamura; P Douglas Boatman; Carleton R Sage; Thomas O Schrader; Ruoping Chen; Steven L Colletti; James R Tata; M Gerard Waters; Kang Cheng; Andrew K Taggart; Tian-Quan Cai; Ester Carballo-Jane; Dominic P Behan; Daniel T Connolly; Jeremy G Richman
Journal:  J Med Chem       Date:  2008-07-30       Impact factor: 7.446

Review 3.  Epac: defining a new mechanism for cAMP action.

Authors:  Martijn Gloerich; Johannes L Bos
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

4.  Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance.

Authors:  Axel Linke; Melanie Sonnabend; Mathias Fasshauer; Robert Höllriegel; Gerhard Schuler; Josef Niebauer; Michael Stumvoll; Matthias Blüher
Journal:  Atherosclerosis       Date:  2008-12-03       Impact factor: 5.162

5.  Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells.

Authors:  Pilaiwan Siripurkpong; Kesara Na-Bangchang
Journal:  J Nutr Biochem       Date:  2008-07-07       Impact factor: 6.048

Review 6.  Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?

Authors:  Heinz Drexel
Journal:  Fundam Clin Pharmacol       Date:  2009-08-14       Impact factor: 2.748

7.  Niacin promotes cholesterol efflux through stimulation of the PPARgamma-LXRalpha-ABCA1 pathway in 3T3-L1 adipocytes.

Authors:  Zhi-Hong Wu; Shui-Ping Zhao
Journal:  Pharmacology       Date:  2009-10-01       Impact factor: 2.547

8.  Effects of niacin on cell adhesion and early atherogenesis: biochemical and functional findings in endothelial cells.

Authors:  Subramaniam Tavintharan; Su Chi Lim; Chee Fang Sum
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-01-21       Impact factor: 4.080

Review 9.  Novel patent publications on high-affinity nicotinic acid receptor agonists.

Authors:  Hong C Shen; Steven L Colletti
Journal:  Expert Opin Ther Pat       Date:  2009-07       Impact factor: 6.674

10.  Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin.

Authors:  Janet E Digby; Eileen McNeill; Oliver J Dyar; Vincent Lam; David R Greaves; Robin P Choudhury
Journal:  Atherosclerosis       Date:  2009-08-31       Impact factor: 5.162

View more
  10 in total

1.  Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients.

Authors:  Miao Hu; Winnie Chiu Wing Chu; Shizuya Yamashita; David Ka Wai Yeung; Lin Shi; Defeng Wang; Daisaku Masuda; Yaling Yang; Brian Tomlinson
Journal:  J Lipid Res       Date:  2012-02-07       Impact factor: 5.922

Review 2.  Niacin in cardiovascular disease: recent preclinical and clinical developments.

Authors:  Janet E Digby; Neil Ruparelia; Robin P Choudhury
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-29       Impact factor: 8.311

3.  Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice.

Authors:  Rebecca E K MacPherson; Laura Castellani; Marie-Soleil Beaudoin; David C Wright
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

4.  Nicotinic acid supplementation in diet favored intramuscular fat deposition and lipid metabolism in finishing steers.

Authors:  Zhu-Qing Yang; Lin-Bin Bao; Xiang-Hui Zhao; Can-Yu Wang; Shan Zhou; Lu-Hua Wen; Chuan-Bian Fu; Jian-Ming Gong; Ming-Ren Qu
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-04

5.  Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia.

Authors:  Miao Hu; Ya-Ling Yang; Daisaku Masuda; Shizuya Yamashita; Brian Tomlinson
Journal:  Dis Markers       Date:  2015-04-29       Impact factor: 3.434

6.  Effects of phenotypic and genotypic factors on the lipid responses to niacin in Chinese patients with dyslipidemia.

Authors:  Miao Hu; Ya-Ling Yang; Chi-Fai Ng; Chui-Ping Lee; Vivian W Y Lee; Hiroyuki Hanada; Daisaku Masuda; Shizuya Yamashita; Brian Tomlinson
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

7.  Niacin improves maturation and cryo-tolerance of bovine in vitro matured oocytes: An experimental study.

Authors:  Mojtaba Kafi; Mahboobeh Ashrafi; Mehdi Azari; Borhan Jandarroodi; Beheshteh Abouhamzeh; Arash Rakhshi Asl
Journal:  Int J Reprod Biomed       Date:  2019-09-22

8.  Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin.

Authors:  B Lindegaard; S Ditlevsen; P Plomgaard; B Mittendorfer; B K Pedersen
Journal:  Diabetologia       Date:  2013-06-29       Impact factor: 10.122

9.  Insulin Signaling in Liver and Adipose Tissues in Periparturient Dairy Cows Supplemented with Dietary Nicotinic Acid.

Authors:  Asako Kinoshita; Ákos Kenéz; Lena Locher; Ulrich Meyer; Sven Dänicke; Jürgen Rehage; Korinna Huber
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

10.  Associations between Forkhead Box O1 (FoxO1) Expression and Indicators of Hepatic Glucose Production in Transition Dairy Cows Supplemented with Dietary Nicotinic Acid.

Authors:  Asako Kinoshita; Lena Locher; Reka Tienken; Ulrich Meyer; Sven Dänicke; Jürgen Rehage; Korinna Huber
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.